Structure-based Design of JOC-x, a Conjugatable Tumor Tight Junction Opener to Enhance Cancer Therapy.

Sci Rep 2019 Apr 16;9(1):6169. Epub 2019 Apr 16.

PAI Life Sciences, Inc., Seattle, WA, USA.

Disorganized intercellular junctions are critical for maintaining the integrity of solid epithelial tumors and prevent the infiltration of oncological therapies into the bulk of the malignancy. We have developed small, recombinant proteins which bind a critical junction protein, desmoglein 2, triggering the transient and specific opening of tumor tight junctions allowing for infiltration of the tumor with immune cells, oncolytic viruses, drugs, and other therapeutics. Our new molecule, JOC-x, is a promising candidate for a new class of tumor-targeting agents that accumulate both around and within tumors and remodel the tumor microenvironment. Native cysteines were removed from the parental protein, JO-4, followed by addition of a single cysteine to allow for convenient attachment of various payloads that can be targeted directly to the tumor. Our tumor-targeting protein exhibits high avidity, minimal aggregation, and is easily purified at good yields from E. coli. For proof of concept, we demonstrate effective conjugation to biotin as a model for flexible co-targeting, addition of metal ion chelators as models for imaging and radiotherapy, and linkage of the TLR3 agonist poly(I:C) as a model immune-oncologic agent. This second-generation cancer co-therapeutic protein is optimized for activity and primed for cGMP manufacture in preparation for upcoming clinical studies.

Download full-text PDF

Publisher Site Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
April 2019
11 Reads

Publication Analysis

Top Keywords

tumor tight
agents accumulate both
accumulate both tumors
tumors remodel
remodel tumor
imaging radiotherapy
candidate class
class tumor-targeting
tumor-targeting agents
models imaging
tumor microenvironment
cysteines removed
ion chelators
removed parental
native cysteines
chelators models
radiotherapy linkage
microenvironment native
parental protein


(Supplied by CrossRef)
Article in Cancer Res
SK Green et al.
Cancer Res 2002
Article in J Exp Biol
SR Lavin et al.
J Exp Biol 2007
Article in Adv Drug Deliv Rev
CA Lipinski et al.
Adv Drug Deliv Rev 2001
Article in Breast Cancer Res Treat
SP Fessler et al.
Breast Cancer Res Treat 2009
Article in J Cell Biochem
C Oliveras-Ferraros et al.
J Cell Biochem 2011
Article in BMC Cancer
CM Lee et al.
BMC Cancer 2010
Article in Clin Cancer Res
I Beyer et al.
Clin Cancer Res 2012
Article in Cancer Res
JJ Christiansen et al.
Cancer Res 2006
Article in PLoS pathogens
ZZ Lu et al.
PLoS pathogens 2013
Article in J Virol
H Wang et al.
J Virol 2011
Article in J Virol
H Wang et al.
J Virol 2013

Similar Publications